GDNF and central nervous system cancer: Previous reports in the literature showed that N-indolylethyl-substituted isoquinuclidines with disconnected heteroarene and isoquinuclidine systems of the iboga skeleton act as potent GDNF-releasers in the C6 glioma cell line [14,15].